Type IIA topoisomerase inhibition by a new class of antibacterial agents

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Nature

• Publication date

  2010-08-19

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/nature09197PMID 20686482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases

  2010cited by this paper
• Crystal structure of the DNA gyrase GyrA N‐terminal domain from Mycobacterium tuberculosis

  2010cited by this paper
• Probing the Differential Interactions of Quinazolinedione PD 0305970 and Quinolones with Gyrase and Topoisomerase IV

  2009cited by this paper
• Structural insight into the quinolone–DNA cleavage complex of type IIA topoisomerases

  2009cited by this paper
• Targeting DNA topoisomerase II in cancer chemotherapy

  2009cited by this paper
• A Crystal Structure of the Bifunctional Antibiotic Simocyclinone D8, Bound to DNA Gyrase

  2009cited by this paper
• Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.

  2009cited by this paper
• Crystal structure of DNA gyrase B′ domain sheds lights on the mechanism for T-segment navigation

  2009cited by this paper
• Effects of magnesium and related divalent metal ions in topoisomerase structure and function

  2009cited by this paper
• Coupling between ATP Binding and DNA Cleavage by DNA Topoisomerase II

  2008cited by this paper
• Mechanism of Action of the Antibiotic NXL101, a Novel Nonfluoroquinolone Inhibitor of Bacterial Type II Topoisomerases

  2008cited by this paper
• DNA topoisomerases: harnessing and constraining energy to govern chromosome topology

  2008cited by this paper
• Human topoisomerase IIα uses a two-metal-ion mechanism for DNA cleavage

  2008cited by this paper
• Multiple modes of Escherichia coli DNA gyrase activity revealed by force and torque

  2007cited by this paper
• Structural studies of E. coli topoisomerase III-DNA complexes reveal a novel type IA topoisomerase-DNA conformational intermediate.

  2007cited by this paper
• Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains.

  2007cited by this paper
• Drugs for bad bugs: confronting the challenges of antibacterial discovery

  2007cited by this paper
• Structural basis for gate-DNA recognition and bending by type IIA topoisomerases

  2007cited by this paper
• Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysis.

  2007cited by this paper
• A “moving metal mechanism” for substrate cleavage by the DNA repair endonuclease APE‐1

  2007cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : Approved standard

  2006cited by this paper
• Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.

  2006cited by this paper
• Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents.

  2005cited by this paper
• Coot: model-building tools for molecular graphics.

  2004cited by this paper
• The PyMOL Molecular Graphics System

  2002cited by this paper
• A robust and scalable microfluidic metering method that allows protein crystal growth by free interface diffusion

  2002cited by this paper
• The role of GyrB in the DNA cleavage-religation reaction of DNA gyrase: a proposed two metal-ion mechanism.

  2002cited by this paper
• A GyrB‐GyrA fusion protein expressed in yeast cells is able to remove DNA supercoils but cannot substitute eukaryotic topoisomerase II

  2002cited by this paper
• A ParE-ParC fusion protein is a functional topoisomerase.

  2001cited by this paper
• Crystal structure of a complex of a type IA DNA topoisomerase with a single-stranded DNA molecule

  2001cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard

  2000cited by this paper
• Mechanism of quinolone resistance in Staphylococcus aureus

  2000cited by this paper
• Similarity in the catalysis of DNA breakage and rejoining by type IA and IIA DNA topoisomerases.

  1999cited by this paper
• Manganese as a Replacement for Magnesium and Zinc: Functional Comparison of the Divalent Ions

  1999cited by this paper
• Identification of Active Site Residues in the “GyrA” Half of Yeast DNA Topoisomerase II*

  1998cited by this paper
• Crystallography & NMR system: A new software suite for macromolecular structure determination.

  1998cited by this paper
• Structural similarities between topoisomerases that cleave one or both DNA strands.

  1998cited by this paper
• Toprim--a conserved catalytic domain in type IA and II topoisomerases, DnaG-type primases, OLD family nucleases and RecR proteins.

  1998cited by this paper
• Refinement of macromolecular structures by the maximum-likelihood method.

  1997cited by this paper
• In the presence of subunit A inhibitors DNA gyrase cleaves DNA fragments as short as 20 bp at specific sites.

  1997cited by this paper
• Crystal structure of the breakage–reunion domain of DNA gyrase

  1997cited by this paper
• DNA cleavage is not required for the binding of quinolone drugs to the DNA gyrase-DNA complex.

  1996cited by this paper
• Structure and mechanism of DNA topoisomerase II

  1996cited by this paper
• Where freedom is given, liberties are taken.

  1995cited by this paper
• The CCP4 suite: programs for protein crystallography.

  1994cited by this paper
• Crystal structure of an N-terminal fragment of the DNA gyrase B protein

  1991cited by this paper
• Probing the limits of the DNA breakage-reunion domain of the Escherichia coli DNA gyrase A protein.

  1991cited by this paper
• Hydrogen Bonding in Biological Structures

  1991cited by this paper
• Mapping the active site tyrosine of Escherichia coli DNA gyrase.

  1987cited by this paper
• DNA gyrase: purification and catalytic properties of a fragment of gyrase B protein.

  1979cited by this paper

• Synthesis, biological evaluation, molecular docking studies, ADME toxicity, enzymatic target prediction, and FMO analysis of aryl thiosemicarbazone analogues

  2026cites this paper
• Structural and Computational Analysis of Pseudomonas aeruginosa DNA Gyrase Reveals Molecular Characteristics That May Contribute to Ciprofloxacin Resistance.

  2026influential citation
• New pyridine-thiazole hybrid systems incorporating pyrazole or coumarin moieties: Design, synthesis, characterization, E/Z isomerism, antimicrobial evaluation, and molecular docking studies

  2026cites this paper
• Gyrase and Topoisomerase IV as Antibacterial Targets for Gepotidacin and Zoliflodacin: Teaching Old Enzymes New Tricks

  2026cites this paper
• Isolation, characterization, and biological evaluation of endophytic fungi from Phragmites australis: experimental and computational insights

  2026cites this paper
• AI-guided competitive docking for virtual screening and compound efficacy prediction

  2026cites this paper
• Chromene-based enaminones: Versatile precursors for the synthesis of new 1-phenyl-1H-pyrazole-3-carboxylate hybrids with potential MRSA inhibitory potency

  2026cites this paper
• ANTIMICROBIAL AND ANTIBIOFILM ACTIVITY OF SUBSTITUTED PYRAZOLES: DESIGN, SYNTHESIS AND MOLECULAR DOCKING STUDIES

  2026cites this paper
• In vitro activity of gepotidacin against a challenging panel of multidrug-resistant Neisseria gonorrhoeae isolates.

  2026cites this paper
• Visible light photocatalytic promoted reactions: Synthesis of polyfunctionally substituted phthalazine derivatives, ADMET, molecular docking and dynamic studies

  2026cites this paper
• Revisiting Copper(II) Schiff Base Complexes of Halogenated Salicylaldehyde 8-Aminoquinoline Derivatives as Promising Antimicrobial Scaffolds: Improved Structural Data, Characterization and Insights into DNA/BSA Binding and ROS

  2026cites this paper
• Indolizinoquinolinedione Metal Complexes: Structural Characterization, In Vitro Antibacterial, and In Silico Studies

  2026influential citation
• Chemical composition and evaluation of the antibacterial and anti-migratory potentials of Anthemis maritima L. growing in North Africa

  2026cites this paper
• Exploration of 1,3-di substituted pyrazole conjugates as DNA gyrase inhibitors to combat Staphylococcus aureus and Mycobacterium tuberculosis.

  2026cites this paper
• 2025 New Drug Update (Part 2): Recent Approvals and Clinical Implications.

  2026cites this paper
• Experimental and molecular docking analyses of antibacterial activity in moroccan Rosmarinus officinalis essential oil

  2026cites this paper
• Oral gepotidacin for the treatment of uncomplicated urinary tract infection in Japanese female patients: a randomized, active reference, double-blind, double-dummy, Phase 3 trial (EAGLE-J).

  2025cites this paper
• Structural and Comparative Stability of a Truncated N‐Terminal Domain of DNA Gyrase A From Salmonella Typhi

  2025cites this paper
• Microwave‐Assisted Synthesis of Bis‐1,2,3‐Triazole‐Based Benzophenones, In Vitro Antimicrobial Activity, and Molecular Docking Studies

  2025cites this paper
• Synthesis and antibacterial evaluation of quinoline–sulfonamide hybrid compounds: a promising strategy against bacterial resistance

  2025cites this paper
• Industry update: the latest developments in the field of therapeutic delivery, March 2025

  2025cites this paper
• The Current Landscape of Antibiotic Use and Antimicrobial Resistance in Japan: Focusing on Common Infections Including Uncomplicated Urinary Tract Infection and Gonorrhea

  2025cites this paper
• Mechanistic Insights into the inhibition of Plasmodium falciparum DNA gyrase A by withanolides derivatives through integrated computational analysis

  2025cites this paper
• New pyrazolyl pyrazole–thiazole hybrids: synthesis, spectral, antimicrobial analysis and molecular docking studies

  2025cites this paper
• Novel 2‐Alkoxy‐3‐Cyanopyridine Derivatives as Cholinesterase Inhibitors: Synthesis, Biological Evaluation, and In Silico Investigations

  2025cites this paper
• Microwave-assisted synthesis and in vitro and in silico studies of pyrano[3,2-c]quinoline-3-carboxylates as dual acting anti-cancer and anti-microbial agents and potential topoisomerase II and DNA-gyrase inhibitors

  2025cites this paper
• Benzothiazole–thiazole hybrids as broad-spectrum antimicrobial agents: synthesis, SAR analysis, and molecular docking against bacterial and fungal targets

  2025cites this paper
• Novel Fluoroquinolones With Pinane Moiety: Synthesis and Antimicrobial Activity

  2025cites this paper
• Anti-Mycobacterial Activity of Bacterial Topoisomerase Inhibitors with Dioxygenated Linkers

  2025cites this paper
• Mechanism of Action of Gepotidacin: Well-Balanced Dual-Targeting against Neisseria gonorrhoeae Gyrase and Topoisomerase IV in Cells and In Vitro

  2025cites this paper
• A stepwise dearomatization/nitration/enantioselective homoenolate reaction of quinolines to construct C3-nitro-substituted tetrahydroquinolines.

  2025cites this paper
• Eco-friendly fabrication of ZnO quantum dots using Brassica rapa (L.): metabolomic profiling and antimicrobial efficacy against foodborne pathogens supported by in-silico insights

  2025cites this paper
• New Quinoline Derivatives as Potential Multitherapeutic Agents: A Facile Synthesis via an Epoxide Ring Opening Reaction, Characterization, DFT Calculations, and Molecular Docking

  2025cites this paper
• In vitro activity of gepotidacin against urinary tract infection isolates of Enterobacterales, Enterococcus faecalis, and Staphylococcus saprophyticus

  2025cites this paper
• New Hybrids of Thiazole Clubbed with Fluorinated Benzene: Design, Synthesis, Spectral, Antimicrobial, and Molecular Docking Studies

  2025cites this paper
• Isolation and Analysis of Rare Enzymatic Events with Multiplex Flow Magnetic Tweezers.

  2025cites this paper
• Development of xanthone derivatives as effective broad-spectrum antimicrobials: Disrupting cell wall and inhibiting DNA synthesis

  2025cites this paper
• 2,4-difluorophenyl(piperidin-4-yl) methanoneoxime derivatives as potent contenders to combat antibacterial resistance of MRSA: In-silico approach

  2025cites this paper
• Copper(II), cobalt(II), nickel(II), and iron(II) mixed complexes formed by Schiff base and 1,10-phenanthroline as secondary chelates: Preparation, characterization, antimicrobial, antioxidant, and molecular docking studies

  2025cites this paper
• ZAB260: A Novel and potent antibacterial agent targeting DNA gyrase

  2025cites this paper
• First report on the synergy of Nepeta menthoides and Nepeta cephalotes essential oils for antimicrobial and preservation applications: A multi-ligand molecular docking simulation

  2025cites this paper
• What's Hot This Year in Infectious Diseases Clinical Science

  2025cites this paper
• Near-infrared light-activated switchable antibacterial agent based on dithienylethene photoswitch

  2025cites this paper
• Structural Mechanisms of Topoisomerase-Targeting Drugs.

  2025cites this paper
• Synthesis of Novel Thiazole/Thiadiazole Conjugates of Fluoroquinolones as Potent Antibacterial and Antimycobacterial Agents

  2025cites this paper
• Gepotidacin: A Novel Antibiotic for the Treatment of Uncomplicated Urinary Tract Infections

  2025cites this paper
• Activities of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284 against the Biothreat Pathogen Bacillus anthracis and Its Type II Topoisomerases

  2025cites this paper
• Structural and Computational Analysis of Pseudomonas aeruginosa DNA Gyrase Reveals Molecular Characteristics That May Contribute to Ciprofloxacin Resistance

  2025influential citation
• Design, Synthesis, Antimicrobial Evaluation, and In Silico Insights of Novel Thiazole‐Based Benzylidene Thiazolidinones as Gyrase Inhibitors

  2025cites this paper
• Structural basis of topoisomerase targeting by delafloxacin

  2025cites this paper
• Eco-friendly Synthesis, antibacterial evaluation and in-silico profiling of Thioamide derivatives as dual-action potential dual-action agents

  2025cites this paper
• Naturally inspired chimeric quinolone derivatives to reverse bacterial drug resistance.

  2025cites this paper
• Synthesis of vanillin-coupled 1, 2, 3-triazoles via click reaction: molecular modeling, structure activity correlation by DFT, ADMET and antibacterial studies

  2025cites this paper
• Antibacterials with Novel Chemical Scaffolds in Clinical Development

  2025cites this paper
• Discovery of DNA Gyrase as a Promising Target against Phytopathogenic Bacteria.

  2025cites this paper
• Choline hydroxide mediated eco-friendly synthesis of 5-arylidene thiazol-4(5H)-one clubbed coumarin: antimicrobial evaluation and in silico studies

  2025influential citation
• Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including subsets with molecularly characterized resistance mechanisms and genotypes/epidemiological clones, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2

  2025cites this paper
• Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including drug-resistant phenotypes, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3)

  2025cites this paper
• High in vitro activity of the novel antimicrobial gepotidacin against Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021–24

  2025cites this paper
• Pharmacokinetic and pharmacodynamic characterization of gepotidacin against Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh infection model

  2025cites this paper
• In vitro activity of gepotidacin against Chlamydia trachomatis

  2025cites this paper
• A green approach to 2-arylquinolines via palladium-catalysed C–H activation

  2025cites this paper
• Unravelling the antibacterial performances of a homochiral d-configured tetraphenylalanine appended 16-HPA derivative based mechanoresponsive and proteolytically stable hydrogel.

  2025cites this paper
• Design and synthesis of naphthyridine-Oxo-4-arylazetidine based derivatives

  2025cites this paper
• AI-guided competitive docking for virtual screening and compound efficacy prediction

  2025cites this paper
• Design and Synthesis of New Pyridine-Thiazole Hybrids as Potential Antibacterial Agents: Spectral, Antimicrobial, and in silico Molecular Docking Studies

  2025cites this paper
• Structural interactions of BWC0977 with Klebsiella pneumoniae topoisomerase IV and biochemical basis of its broad-spectrum activity

  2025cites this paper
• Novel 1,3,4-Oxadiazolyltriazole-Derived Phthalazine Scaffolds: Design, Synthesis, Bioactive Evaluation and Computational Docking Study

  2025cites this paper
• Harnessing biological insights to accelerate drug discovery against ESKAPE pathogens.

  2025cites this paper
• Bioactivity-guided study of a novel endophytic Aspergillus terreus from Canthium coromandelicum: antioxidant, anticancer, antimicrobial properties and in silico toxicity, ADME and docking predictions.

  2025cites this paper
• Impact of updated regulatory guidelines on study results in contemporary uncomplicated urinary tract infection clinical trials and implications for trial conduct and drug development: a comparative analysis with EAGLE-2 and EAGLE-3

  2025cites this paper
• Silver‐Enabled Inverse Electron Demand Thermal Decarbonylative Skeletal Expansion: A New Gateway to the Synthesis of Multifunctionalized Quinoline

  2025cites this paper
• Structural and Mechanistic Insights into Atypical Bacterial Topoisomerase Inhibitors

  2025cites this paper
• Quinoxaline Clubbed Thiazole: Molecular Docking, Synthesis and Antimicrobial Evaluation

  2024cites this paper
• Investigating the Molecular Interactions of 11-substituted-1-(4-chlorophenyl)-8H-indolo[3,2-c][1,2,4]triazolo[3,4-a]isoquinolines for Antimicrobial Potential: Synthesis, Spectral, In vitro and In silico Study Interpretations

  2024cites this paper
• Dynamic Profiling and Binding Affinity Prediction of NBTI Antibacterials against DNA Gyrase Enzyme by Multidimensional Machine Learning and Molecular Dynamics Simulations

  2024cites this paper
• In vitro activity of gepotidacin and comparator antimicrobials against isolates of nontuberculous mycobacteria (NTM)

  2024cites this paper
• Copper-Catalyzed [4+1+1] Annulation of Ammonium Salts and Anthranils: Synthesis of 2,3-Diaroylquinolines.

  2024cites this paper
• Structural basis of DNA crossover capture by Escherichia coli DNA gyrase

  2024cites this paper
• Highly sensitive mapping of in vitro type II topoisomerase DNA cleavage sites with SHAN-seq

  2024cites this paper
• Target-Mediated Fluoroquinolone Resistance in Neisseria gonorrhoeae: Actions of Ciprofloxacin against Gyrase and Topoisomerase IV

  2024cites this paper
• Spectroscopic characterization, DFT calculations, in vitro pharmacological potentials, and molecular docking studies of an N, N, O-Schiff base and its trivalent metal complexes

  2024cites this paper
• Structure-function analysis of the ATPase domain of African swine fever virus topoisomerase

  2024cites this paper
• Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting

  2024cites this paper
• Efficacy of therapeutically administered gepotidacin in a rabbit model of inhalational anthrax

  2024cites this paper
• A Comprehensive Investigation of ethyl 2-(3-methoxybenzyl) acrylate Substituted Pyrazolone Analogue: Synthesis, Computational and Biological Studies

  2024cites this paper
• Synthesis and antibacterial evaluation of new naphthalimide-coumarin hybrids against multidrug-resistant S. aureus and M. tuberculosis

  2024cites this paper
• Gyrase and Topoisomerase IV: Recycling Old Targets for New Antibacterials to Combat Fluoroquinolone Resistance

  2024cites this paper
• Synthesis, characterization, antimicrobial activity and molecular docking study of transition metal complexes based on azo coumarin and thiosemicarbazone derivative

  2024cites this paper
• Management of Neisseria gonorrhoeae infection: from drug resistance to drug repurposing

  2024influential citation
• Novel terpyridines as Staphylococcus aureus gyrase inhibitors: efficient synthesis and antibacterial assessment via solvent-drop grinding.

  2024cites this paper
• Developing Effective Antimicrobial Agents: Synthesis and Molecular Docking Study of Ciprofloxacin‐Benzimidazole Hybrids

  2024cites this paper
• In Vitro and In Silico Evaluations of Cardanol and Derivatives from Cashew Nut-Shell

  2024cites this paper
• Antimicrobial activity of hydralazine against methicillin-resistant and methicillin-susceptible Staphylococcus aureus.

  2024cites this paper
• Intermethod comparability analyses of gepotidacin antimicrobial susceptibility tests using a large collection of globally collected Escherichia coli and Staphylococcus saprophyticus clinical isolates.

  2024cites this paper
• Unlocking Opportunities for Mycobacterium leprae and Mycobacterium ulcerans

  2024cites this paper
• Two classes of DNA gyrase inhibitors elicit distinct evolutionary trajectories toward resistance in gram-negative pathogens

  2024cites this paper
• How Do Gepotidacin and Zoliflodacin Stabilize DNA-Cleavage Complexes with Bacterial Type IIA Topoisomerases? 2. A Single Moving Metal Mechanism

  2024cites this paper
• Fighting Antimicrobial Resistance: Innovative Drugs in Antibacterial Research

  2024cites this paper
• Gepotidacin, a new first-in-class antibiotic for treating uncomplicated urinary tract infection.

  2024cites this paper